Navigator

      Support By : Li-lab

Drug-Pathway
DRUGs and PATHWAYs
PATHWAY_NAME REACTOME_ID KEGG_ID DRUG_NAME PUBCHEM_CID Datasource
Neuroactive ligand-receptor interaction R-HSA-5632681 map04080 sulfafurazole 54459 drug-path
Jak-STAT signaling pathway R-HSA-168638 map04630 sulfafurazole 54459 drug-path
Cytokine-cytokine receptor interaction R-HSA-6788467 map04060 sulfafurazole 54459 drug-path
Type I diabetes mellitus R-HSA-5683209 map04940 sulfafurazole 54459 drug-path
Graft-versus-host disease R-HSA-1643685 map05332 phenylpropanolamine 4786 drug-path
Natural killer cell mediated cytotoxicity R-HSA-5218921 map04650 phenylpropanolamine 4786 drug-path
Hematopoietic cell lineage R-HSA-173752 map04640 phenylpropanolamine 4786 drug-path
Autoimmune thyroid disease R-HSA-1643685 map05320 phenylpropanolamine 4786 drug-path
Antigen processing and presentation R-HSA-1236975 map04612 phenylpropanolamine 4786 drug-path
Leukocyte transendothelial migration R-HSA-8950732 map04670 phenylpropanolamine 4786 drug-path
Olfactory transduction R-HSA-9751605 map04740 phenylpropanolamine 4786 drug-path
Cell adhesion molecules (CAMs) R-HSA-1031690 0 phenylpropanolamine 4786 drug-path
Systemic lupus erythematosus R-HSA-977105 map05322 phenylpropanolamine 4786 drug-path
Asthma R-HSA-444620 map05310 phenylpropanolamine 4786 drug-path
Regulation of actin cytoskeleton R-HSA-392751 map04810 phenylpropanolamine 4786 drug-path
Allograft rejection R-HSA-9679028 map05330 phenylpropanolamine 4786 drug-path
Type I diabetes mellitus R-HSA-5683209 map04940 phenylpropanolamine 4786 drug-path
GnRH signaling pathway R-HSA-168638 map04912 phenylpropanolamine 4786 drug-path
SNARE interactions in vesicular transport R-HSA-428625 map04130 C-75 4248455 drug-path
Hematopoietic cell lineage R-HSA-173752 map04640 C-75 4248455 drug-path